Endocrine/Metabolic

INDICATION: Diabetes

Cell culture studies suggest inhibiting TGFBR1 could help treat GLIS3-mutant diabetes. Screening of a library of approved drugs, drug-like

Read the full 200 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE